Product Information
ACETAMINOPHEN 650 MG SUPPOS is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.3395 per EA under NDC 45802073033. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
650 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802073033
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Last Updated
6/17/2026
Active Ingredients
ACETAMINOPHENApproval Type
Generic (ANDA)
FDA Application
ANDA070608On Market Since
10/28/2010
Price Statistics
The NADAC for ACETAMINOPHEN 650 MG SUPPOS has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 24.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3395 per EA |
|---|---|
| All-time high | $0.5002 (Sep 10, 2014) |
| All-time low | $0.2796 (Dec 20, 2017) |
| 52-week high | $0.3472 |
| 52-week low | $0.3340 |
| Median price | $0.3422 |
| Average price | $0.3511 |
| Largest weekly change | +40.3% (Dec 17, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 650 MG SUPPOS?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 650 MG SUPPOS, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.3395 per EA (NDC 45802073033), effective Jun 24, 2026.
How has the price of ACETAMINOPHEN 650 MG SUPPOS changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 650 MG SUPPOS has declined 24.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 650 MG SUPPOS?
Since Nov 28, 2013, the NADAC for ACETAMINOPHEN 650 MG SUPPOS has ranged from a low of $0.2796 (Dec 20, 2017) to a high of $0.5002 (Sep 10, 2014), with a median of $0.3422 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 650 MG SUPPOS?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ARTHRITIS PAIN ER 650 MG CAPLT, is $0.0599 per EA — about 82% below ACETAMINOPHEN 650 MG SUPPOS.
Who manufactures ACETAMINOPHEN 650 MG SUPPOS?
ACETAMINOPHEN 650 MG SUPPOS (NDC 45802073033) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification